Serological Survey: 21% Indians Had Suffered From COVID-19 By Mid-December
Posted by
www.biotecnika.org
ICMR's (Indian Council of Scientific Research) third nationwide
serological-survey report stated that more than 21% of the Indian
population of age 18 and above, presented proof of prior exposure to
COVID-19. The report of seroprevalence within the 10-17 age group was
identified to be 25.3%. In spite of this, a huge section of citizens
is […]
The post Serological Survey: 21% Indians Had Suffered From COVID-19 By
Mid-December appeared first on BioTecNika .
https://www.biotecnika.org/2021/02/icmrs-serological-survey-showed-21-seroprevalence-for-indian-adults/
Biotech News
Subscribe to:
Post Comments (Atom)
June 23, 2023 at 2:59 AM
Thank you. I understand and will take note. Share more information like this.
August 27, 2025 at 8:59 PM
I wonder if future surveys will factor in vaccination rates alongside seroprevalence. Let's play pako highway while we wait for more data.
September 16, 2025 at 12:45 AM
Interesting data—the higher seroprevalence among the 10–17 age group is particularly striking. It really highlights how widespread Crazy Cattle 3D exposure was by the end of 2020, even among younger people. Continued vaccination and monitoring remain so important as we learn more from these surveys.
October 15, 2025 at 8:44 PM
Pips NYT is easy enough for casual players but deep enough for puzzle enthusiasts. It’s a great way to challenge your brain while still feeling calm and focused.
November 5, 2025 at 3:14 AM
It took me a little while to read all of the comments, but I found the article to be quite intriguing.
December 17, 2025 at 8:05 PM
So, the serology survey says 21% of Indians had COVID by mid-December, but the comment section is a wild ride from pandemic data to unsolicited gaming ads. Did I accidentally click on a blog or a pop-up arcade? Want to play a more exciting minesweeper game and find more traps, try it out in Minesweeper Plus.
December 17, 2025 at 8:05 PM
So the article is about a serious COVID-19 serological survey, but scrolling through the comments feels like someone spilled a bag of gaming ads into a science discussion. Truly a modern internet experience: one part pandemic data, three parts "download this app!" Want to generate a favorite image or a very beautiful image, you can do so in Flux2
December 17, 2025 at 8:05 PM
So the article is about a serious COVID-19 serological survey, but scrolling through the comments feels like someone spilled a bag of gaming ads into a science discussion. Truly a modern internet experience: one part pandemic data, three parts "download this app!" Want to generate a favorite image or a very beautiful image, you can do so in Flux2. Ignite Your Creative Genius! With AI-powered magic, instantly transform, restyle, or reinvent any photo. Go from ordinary to extraordinary visuals in a snap and let your imagination soar，Come try Image to Image!
December 17, 2025 at 8:09 PM
Ah, the classic internet bait-and-switch: come for the sobering pandemic statistics, stay for the unsolicited gaming arcade. Nothing says "serious public health discussion" like a side of "Bird Game 3." Truly, a digital ecosystem in perfect balance. If you want to play a fun level-breaking game, you can play as a fire rack to stop the rain from falling and pass the level smoothly, right in Storm Grill
December 18, 2025 at 6:25 PM
The serological survey highlights the significant impact of COVID-19 in India, especially among adults and younger populations. It's a reminder of the importance of continued vigilance and research. For more insights and updates, visit bounce path, your trusted source for reliable information!
December 27, 2025 at 6:01 PM
This serological data is crucial for understanding COVID-19's spread. It underscores the need for accessible health information. For a strategic diversion, Pokepath TD offers a thoughtful tower defense experience. It involves training and evolving a team to overcome challenges, with progress saved for continuous growth, providing a rewarding mental engagement.
Post a Comment